Junye Ma, Gregory E Chase, Ashley Black, Jonathan Klaphake, Kelly Garcia-Myers, Jason V Baker, Keith J Horvath
{"title":"性少数群体中的新兴男性和年轻成年男性对生物医学艾滋病预防策略有效性的态度和信念。","authors":"Junye Ma, Gregory E Chase, Ashley Black, Jonathan Klaphake, Kelly Garcia-Myers, Jason V Baker, Keith J Horvath","doi":"10.1007/s12529-023-10244-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Pre-exposure prophylaxis (PrEP) and HIV treatment as prevention, which underlies the Undetectable = Untransmittable (U = U) campaign, are two effective biomedical approaches for HIV prevention among sexual minority men (SMM). Attitudes toward PrEP and U = U may differ between SMM emerging adults (EA: 18-24 years old) and young adults (YA: 25-29 years old) to drive differences in sexual behavior. However, to date, few studies assessed the degree to which YAs and EAs differ in their beliefs in the effectiveness of PrEP and U = U.</p><p><strong>Method: </strong>A national sample of 80 SMM in the USA (M<sub>age</sub> = 25.1 years; 53.7% racial/ethnic minority; 38.8% EA; 61.3% YA) participated in a 6-month mHealth intervention for PrEP adherence. Non-parametric tests assessed differences in sexual behaviors and attitudes toward the effectiveness of PrEP and U = U between EAs and YAs using baseline data.</p><p><strong>Results: </strong>Compared to EAs, higher proportions of YAs trusted PrEP's effectiveness and considered condom use unnecessary after taking PrEP. More YAs than EAs were willing to engage in sexual behaviors that they felt too risky before learning about U = U and were more comfortable having condomless sex with HIV-positive partners. Conversely, a greater proportion of EAs than YAs preferred to use condoms even when their partners are on anti-HIV medications.</p><p><strong>Conclusion: </strong>Overall, YAs trusted the effectiveness of U = U and PrEP more than EAs, underscoring developmental differences in SMM's perspectives on biomedical HIV prevention tools. Our findings underscore the importance of tailoring messages on biomedical HIV prevention options differently for EAs and YAs to optimize uptake.</p>","PeriodicalId":54208,"journal":{"name":"International Journal of Behavioral Medicine","volume":" ","pages":"142-148"},"PeriodicalIF":2.0000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11187700/pdf/","citationCount":"0","resultStr":"{\"title\":\"Attitudes Toward and Beliefs in the Effectiveness of Biomedical HIV Prevention Strategies Among Emerging and Young Adult Sexual Minority Men.\",\"authors\":\"Junye Ma, Gregory E Chase, Ashley Black, Jonathan Klaphake, Kelly Garcia-Myers, Jason V Baker, Keith J Horvath\",\"doi\":\"10.1007/s12529-023-10244-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Pre-exposure prophylaxis (PrEP) and HIV treatment as prevention, which underlies the Undetectable = Untransmittable (U = U) campaign, are two effective biomedical approaches for HIV prevention among sexual minority men (SMM). Attitudes toward PrEP and U = U may differ between SMM emerging adults (EA: 18-24 years old) and young adults (YA: 25-29 years old) to drive differences in sexual behavior. However, to date, few studies assessed the degree to which YAs and EAs differ in their beliefs in the effectiveness of PrEP and U = U.</p><p><strong>Method: </strong>A national sample of 80 SMM in the USA (M<sub>age</sub> = 25.1 years; 53.7% racial/ethnic minority; 38.8% EA; 61.3% YA) participated in a 6-month mHealth intervention for PrEP adherence. Non-parametric tests assessed differences in sexual behaviors and attitudes toward the effectiveness of PrEP and U = U between EAs and YAs using baseline data.</p><p><strong>Results: </strong>Compared to EAs, higher proportions of YAs trusted PrEP's effectiveness and considered condom use unnecessary after taking PrEP. More YAs than EAs were willing to engage in sexual behaviors that they felt too risky before learning about U = U and were more comfortable having condomless sex with HIV-positive partners. Conversely, a greater proportion of EAs than YAs preferred to use condoms even when their partners are on anti-HIV medications.</p><p><strong>Conclusion: </strong>Overall, YAs trusted the effectiveness of U = U and PrEP more than EAs, underscoring developmental differences in SMM's perspectives on biomedical HIV prevention tools. Our findings underscore the importance of tailoring messages on biomedical HIV prevention options differently for EAs and YAs to optimize uptake.</p>\",\"PeriodicalId\":54208,\"journal\":{\"name\":\"International Journal of Behavioral Medicine\",\"volume\":\" \",\"pages\":\"142-148\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2025-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11187700/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Behavioral Medicine\",\"FirstCategoryId\":\"102\",\"ListUrlMain\":\"https://doi.org/10.1007/s12529-023-10244-4\",\"RegionNum\":3,\"RegionCategory\":\"心理学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/12/19 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"PSYCHOLOGY, CLINICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Behavioral Medicine","FirstCategoryId":"102","ListUrlMain":"https://doi.org/10.1007/s12529-023-10244-4","RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/12/19 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PSYCHOLOGY, CLINICAL","Score":null,"Total":0}
引用次数: 0
摘要
背景:暴露前预防(PrEP)和艾滋病治疗作为预防措施,是 "检测不到=无法传播(U = U)"运动的基础,也是在性少数群体男性(SMM)中预防艾滋病的两种有效的生物医学方法。性少数人群中的新兴成年人(EA:18-24 岁)和年轻成年人(YA:25-29 岁)对 PrEP 和 U = U 的态度可能不同,从而导致性行为的差异。然而,迄今为止,很少有研究对青年和成年在对 PrEP 和 U = U 的有效性的信念上的差异程度进行评估:在美国,80 名 SMM(年龄 = 25.1 岁;53.7% 为少数种族/族裔;38.8% 为 EA;61.3% 为 YA)参加了为期 6 个月的移动医疗干预,以促进 PrEP 的坚持。利用基线数据,非参数检验评估了 EA 和 YA 之间在性行为和对 PrEP 效果的态度以及 U = U 方面的差异:与 EAs 相比,更多的 YAs 相信 PrEP 的有效性,并认为在服用 PrEP 后无需使用安全套。在了解 U = U 之前,有更多的青年艾滋病患者愿意从事他们认为风险过高的性行为,并且更愿意与 HIV 阳性伴侣进行无安全套性行为。相反,与青年艾滋病人相比,更多的青年艾滋病人倾向于使用安全套,即使他们的伴侣正在服用抗艾滋病毒药物:总体而言,青年艾滋病患者比成年艾滋病患者更相信 U = U 和 PrEP 的有效性,这突出表明了 SMM 对生物医学艾滋病预防工具的看法存在发展差异。我们的研究结果强调了以不同的方式为 EAs 和 YAs 定制生物医学艾滋病预防方案信息的重要性,以优化吸收率。
Attitudes Toward and Beliefs in the Effectiveness of Biomedical HIV Prevention Strategies Among Emerging and Young Adult Sexual Minority Men.
Background: Pre-exposure prophylaxis (PrEP) and HIV treatment as prevention, which underlies the Undetectable = Untransmittable (U = U) campaign, are two effective biomedical approaches for HIV prevention among sexual minority men (SMM). Attitudes toward PrEP and U = U may differ between SMM emerging adults (EA: 18-24 years old) and young adults (YA: 25-29 years old) to drive differences in sexual behavior. However, to date, few studies assessed the degree to which YAs and EAs differ in their beliefs in the effectiveness of PrEP and U = U.
Method: A national sample of 80 SMM in the USA (Mage = 25.1 years; 53.7% racial/ethnic minority; 38.8% EA; 61.3% YA) participated in a 6-month mHealth intervention for PrEP adherence. Non-parametric tests assessed differences in sexual behaviors and attitudes toward the effectiveness of PrEP and U = U between EAs and YAs using baseline data.
Results: Compared to EAs, higher proportions of YAs trusted PrEP's effectiveness and considered condom use unnecessary after taking PrEP. More YAs than EAs were willing to engage in sexual behaviors that they felt too risky before learning about U = U and were more comfortable having condomless sex with HIV-positive partners. Conversely, a greater proportion of EAs than YAs preferred to use condoms even when their partners are on anti-HIV medications.
Conclusion: Overall, YAs trusted the effectiveness of U = U and PrEP more than EAs, underscoring developmental differences in SMM's perspectives on biomedical HIV prevention tools. Our findings underscore the importance of tailoring messages on biomedical HIV prevention options differently for EAs and YAs to optimize uptake.
期刊介绍:
The International Journal of Behavioral Medicine (IJBM) is the official scientific journal of the International Society for Behavioral Medicine (ISBM). IJBM seeks to present the best theoretically-driven, evidence-based work in the field of behavioral medicine from around the globe. IJBM embraces multiple theoretical perspectives, research methodologies, groups of interest, and levels of analysis. The journal is interested in research across the broad spectrum of behavioral medicine, including health-behavior relationships, the prevention of illness and the promotion of health, the effects of illness on the self and others, the effectiveness of novel interventions, identification of biobehavioral mechanisms, and the influence of social factors on health. We welcome experimental, non-experimental, quantitative, qualitative, and mixed-methods studies as well as implementation and dissemination research, integrative reviews, and meta-analyses.